These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 30921566)
41. Reversal effect of quercetin on multidrug resistance via FZD7/β-catenin pathway in hepatocellular carcinoma cells. Chen Z; Huang C; Ma T; Jiang L; Tang L; Shi T; Zhang S; Zhang L; Zhu P; Li J; Shen A Phytomedicine; 2018 Apr; 43():37-45. PubMed ID: 29747752 [TBL] [Abstract][Full Text] [Related]
42. β-Casein micelles for oral delivery of SN-38 and elacridar to overcome BCRP-mediated multidrug resistance in gastric cancer. Bar-Zeev M; Kelmansky D; Assaraf YG; Livney YD Eur J Pharm Biopharm; 2018 Dec; 133():240-249. PubMed ID: 30367935 [TBL] [Abstract][Full Text] [Related]
43. Mechanistic analysis of taxol-induced multidrug resistance in an ovarian cancer cell line. Wang NN; Zhao LJ; Wu LN; He MF; Qu JW; Zhao YB; Zhao WZ; Li JS; Wang JH Asian Pac J Cancer Prev; 2013; 14(9):4983-8. PubMed ID: 24175763 [TBL] [Abstract][Full Text] [Related]
44. Dacomitinib potentiates the efficacy of conventional chemotherapeutic agents via inhibiting the drug efflux function of ABCG2 in vitro and in vivo. Guo X; To KKW; Chen Z; Wang X; Zhang J; Luo M; Wang F; Yan S; Fu L J Exp Clin Cancer Res; 2018 Feb; 37(1):31. PubMed ID: 29458405 [TBL] [Abstract][Full Text] [Related]
45. Bipiperidinyl derivatives of 23-hydroxybetulinic acid reverse resistance of HepG2/ADM and MCF-7/ADR cells. Zhang DM; Li YJ; Shu C; Ruan ZX; Chen WM; Yiu A; Peng YH; Wang J; Lan P; Yao Z; Fung KP; Fu LW; Chen ZS; Ye WC Anticancer Drugs; 2013 Jun; 24(5):441-54. PubMed ID: 23466650 [TBL] [Abstract][Full Text] [Related]
46. Cytotoxic activity of medicinal plants of the Kakamega County (Kenya) against drug-sensitive and multidrug-resistant cancer cells. Ochwang'i DO; Kimwele CN; Oduma JA; Gathumbi PK; Kiama SG; Efferth T J Ethnopharmacol; 2018 Apr; 215():233-240. PubMed ID: 29309859 [TBL] [Abstract][Full Text] [Related]
47. LRIG1, human EGFR inhibitor, reverses multidrug resistance through modulation of ABCB1 and ABCG2. Liu B; Guo Z; Dong H; Daofeng T; Cai Q; Ji B; Zhang S; Wu L; Wang J; Wang L; Zhu X; Liu Y; Chen Q Brain Res; 2015 Jun; 1611():93-100. PubMed ID: 25801120 [TBL] [Abstract][Full Text] [Related]
48. ABCB1-dependent collateral sensitivity of multidrug-resistant colorectal cancer cells to the survivin inhibitor MX106-4C. Lei ZN; Albadari N; Teng QX; Rahman H; Wang JQ; Wu Z; Ma D; Ambudkar SV; Wurpel JND; Pan Y; Li W; Chen ZS Drug Resist Updat; 2024 Mar; 73():101065. PubMed ID: 38367548 [TBL] [Abstract][Full Text] [Related]
50. Chloride channel-3 mediates multidrug resistance of cancer by upregulating P-glycoprotein expression. Chen Q; Liu X; Luo Z; Wang S; Lin J; Xie Z; Li M; Li C; Cao H; Huang Q; Mao J; Xu B J Cell Physiol; 2019 May; 234(5):6611-6623. PubMed ID: 30230544 [TBL] [Abstract][Full Text] [Related]
51. Effects of Kampo medicines on MDR-1-mediated multidrug resistance in human hepatocellular carcinoma HuH-7/PTX cells. Hyuga S; Shiraishi M; Hori A; Hyuga M; Hanawa T Biol Pharm Bull; 2012; 35(10):1729-39. PubMed ID: 23037162 [TBL] [Abstract][Full Text] [Related]
52. SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer. Santolla MF; Avino S; Pellegrino M; De Francesco EM; De Marco P; Lappano R; Vivacqua A; Cirillo F; Rigiracciolo DC; Scarpelli A; Abonante S; Maggiolini M Cell Death Dis; 2015 Jul; 6(7):e1834. PubMed ID: 26225773 [TBL] [Abstract][Full Text] [Related]
53. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells. Cheng Z; Yang N; Liang W; Yan X; Li L; Pan L Leuk Lymphoma; 2012 Jul; 53(7):1383-9. PubMed ID: 22185283 [TBL] [Abstract][Full Text] [Related]
54. Vatalanib sensitizes ABCB1 and ABCG2-overexpressing multidrug resistant colon cancer cells to chemotherapy under hypoxia. To KK; Poon DC; Wei Y; Wang F; Lin G; Fu LW Biochem Pharmacol; 2015 Sep; 97(1):27-37. PubMed ID: 26206183 [TBL] [Abstract][Full Text] [Related]
55. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents. Qian J; Xia M; Liu W; Li L; Yang J; Mei Y; Meng Q; Xie Y Eur J Pharmacol; 2019 Jun; 852():231-243. PubMed ID: 30959046 [TBL] [Abstract][Full Text] [Related]
56. Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo. Hu J; Zhang X; Wang F; Wang X; Yang K; Xu M; To KK; Li Q; Fu L Oncotarget; 2015 Dec; 6(42):44643-59. PubMed ID: 26556876 [TBL] [Abstract][Full Text] [Related]
57. Not only P-glycoprotein: Amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins. Genovese I; Ilari A; Assaraf YG; Fazi F; Colotti G Drug Resist Updat; 2017 May; 32():23-46. PubMed ID: 29145976 [TBL] [Abstract][Full Text] [Related]
59. Transcriptional modulation of BCRP gene to reverse multidrug resistance by toremifene in breast adenocarcinoma cells. Zhang Y; Wang H; Wei L; Li G; Yu J; Gao Y; Gao P; Zhang X; Wei F; Yin D; Zhou G Breast Cancer Res Treat; 2010 Oct; 123(3):679-89. PubMed ID: 19967559 [TBL] [Abstract][Full Text] [Related]
60. Ceritinib Enhances the Efficacy of Substrate Chemotherapeutic Agent in Human ABCB1-Overexpressing Leukemia Cells In Vitro, In Vivo and Ex-Vivo. Yang L; Li M; Wang F; Zhen C; Luo M; Fang X; Zhang H; Zhang J; Li Q; Fu L Cell Physiol Biochem; 2018; 46(6):2487-2499. PubMed ID: 29742496 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]